查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519387

2024-2032 年按癌症類型、技術（下一代定序、聚合酶鏈反應、免疫組織化學、原位雜合技術、微陣列等）、技術、應用和區域分類的癌症/腫瘤分析市場報告

Cancer/Tumor Profiling Market Report by Cancer Type, Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Microarray, and Others), Technique, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球癌症/腫瘤分析市場規模達到 115 億美元。

癌症/腫瘤分析，也稱為生物標記測試，是指用於識別腫瘤組織樣本中的特定蛋白質、基因或基因突變（變化）以及其他生物標記的實驗室測試或程序。它幫助腫瘤學家確定患者腫瘤的途徑是否與可用的標靶治療相符。它還有助於常規診斷、治療決策，以及根據個人疾病的嚴重程度和基因組構建制定個人化的治療計劃和療法。癌症/腫瘤分析也廣泛應用於個人化醫療、研究、生物標記的發現以及篩檢和診斷技術的開發。

癌症/腫瘤分析市場趨勢：

癌症/腫瘤分析廣泛應用於藥物設計、發現和開發過程中的腫瘤學研究和生物標記的發現。因此，癌症在全球的廣泛流行是推動市場成長的主要因素。除此之外，對診斷和腫瘤分析的生物標記的日益關注以及大眾對個人化醫療的偏好的轉變正在增加產品需求。此外，政府對癌症研究的資助和支持也顯著增加，以開發先進技術，以減少腫瘤檢測和識別所需的時間。同時，分子生物學技術（例如下一代定序（NGS））的最新進展正在加速癌症/腫瘤分析的採用。此外，製藥和生物技術公司為推出新療法和新藥物設計技術而增加對研發（R＆D）活動的​​投資正在推動市場成長。其他因素，包括臨床試驗數量的增加、免疫分析技術的日益採用、有利的報銷政策、醫療基礎設施的改善和技術進步，也為市場創造了積極的前景。

本報告回答的關鍵問題

  • 2023 年全球癌症/腫瘤分析市場規模有多大？
  • 2024-2032 年全球癌症/腫瘤分析市場的預期成長率是多少？
  • COVID-19 對全球癌症/腫瘤分析市場有何影響？
  • 推動全球癌症/腫瘤分析市場的關鍵因素是什麼？
  • 根據癌症類型，全球癌症/腫瘤分析市場的細分如何？
  • 基於該技術的全球癌症/腫瘤分析市場的細分如何？
  • 全球癌症/腫瘤分析市場的關鍵區域有哪些？
  • 全球癌症/腫瘤分析市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球癌症/腫瘤分析市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依癌症類型

  • 乳癌
    • 市場走向
    • 市場預測
  • 肺癌
    • 市場走向
    • 市場預測
  • 大腸直腸癌
    • 市場走向
    • 市場預測
  • 攝護腺癌
    • 市場走向
    • 市場預測
  • 黑色素瘤
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依技術

  • 新一代定序 (NGS)
    • 市場走向
    • 市場預測
  • 聚合酶鍊式反應 (PCR)
    • 市場走向
    • 市場預測
  • 免疫組織化學 (IHC)
    • 市場走向
    • 市場預測
  • 原位雜合技術 (ISH)
    • 市場走向
    • 市場預測
  • 微陣列
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依技術

  • 基因組學
    • 市場走向
    • 市場預測
  • 蛋白質體學
    • 市場走向
    • 市場預測
  • 表觀遺傳學
    • 市場走向
    • 市場預測
  • 代謝組學
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 個人化醫療
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測
  • 生物標記發現
    • 市場走向
    • 市場預測
  • 預測
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Caris Life Sciences
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • HTG Molecular Diagnostics Inc.
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • NeoGenomics Laboratories
    • Qiagen NV
    • Siemens AG
    • Sysmex Corporation
Product Code: SR112024A5231

The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.

Cancer/tumor profiling, also known as biomarker testing, refers to a laboratory test or procedure used to identify specific proteins, genes or gene mutations (changes) and other biomarkers in a tumor tissue sample. It assists oncologists in determining if the pathways of a patient's tumor match up with the available targeted therapies. It also aids in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals based on the severity of their ailment and genomic build-up. Cancer/tumor profiling also finds extensive applications in personalized medicine, research, the discovery of biomarkers, and the development of screening and diagnostic techniques.

Cancer/Tumor Profiling Market Trends:

Cancer/tumor profiling is widely used in oncology research and discovery of biomarkers during the process of drug design, discovery and development. As a result, the widespread prevalence of cancer across the globe represents the primary factor driving the market growth. Besides this, the growing focus on biomarkers for diagnosis and tumor profiling and the shifting preferences toward personalized medicine among the masses are augmenting the product demand. Additionally, there has been a significant rise in government funding and support for cancer research for the development of advanced techniques to reduce the time taken for the detection and identification of tumors. Along with this, the recent advancements in molecular biology techniques, such as next-generation sequencing (NGS), are accelerating the adoption of cancer/tumor profiling. Furthermore, the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for the launch of novel therapies and new drug designing techniques are propelling the market growth. Other factors, including the rising number of clinical trials, growing adoption of immunoassay techniques, favorable reimbursement policies, improving healthcare infrastructure, and technological advancements, are also creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer/tumor profiling market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, technology, technique and application.

Breakup by Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma Cancer

Others

Breakup by Technology:

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In-Situ Hybridization (ISH)

Microarray

Others

Breakup by Technique:

Genomics

Proteomics

Epigenetics

Metabolomics

Breakup by Application:

Personalized Medicine

Diagnostics

Biomarker Discovery

Prognostics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global cancer/tumor profiling market in 2023?
  • 2. What is the expected growth rate of the global cancer/tumor profiling market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?
  • 4. What are the key factors driving the global cancer/tumor profiling market?
  • 5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?
  • 6. What is the breakup of the global cancer/tumor profiling market based on the technique?
  • 7. What are the key regions in the global cancer/tumor profiling market?
  • 8. Who are the key players/companies in the global cancer/tumor profiling market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer/Tumor Profiling Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lung Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prostate Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Melanoma Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Next-Generation Sequencing (NGS)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymerase Chain Reaction (PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry (IHC)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 In-Situ Hybridization (ISH)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Microarray
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technique

  • 8.1 Genomics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Proteomics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Epigenetics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Metabolomics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Personalized Medicine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Biomarker Discovery
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Prognostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Caris Life Sciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Exact Sciences Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Hologic Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 HTG Molecular Diagnostics Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Laboratory Corporation of America Holdings
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 NeoGenomics Laboratories
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Siemens AG
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sysmex Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cancer/Tumor Profiling Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer/Tumor Profiling Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cancer/Tumor Profiling Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cancer/Tumor Profiling Market: Breakup by Cancer Type (in %), 2023
  • Figure 5: Global: Cancer/Tumor Profiling Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Cancer/Tumor Profiling Market: Breakup by Technique (in %), 2023
  • Figure 7: Global: Cancer/Tumor Profiling Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Cancer/Tumor Profiling Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Cancer/Tumor Profiling (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cancer/Tumor Profiling (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cancer/Tumor Profiling (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cancer/Tumor Profiling (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cancer/Tumor Profiling (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cancer/Tumor Profiling (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cancer/Tumor Profiling (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cancer/Tumor Profiling (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cancer/Tumor Profiling (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cancer/Tumor Profiling (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Cancer/Tumor Profiling (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Cancer/Tumor Profiling (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Cancer/Tumor Profiling (Genomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Cancer/Tumor Profiling (Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Cancer/Tumor Profiling (Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Cancer/Tumor Profiling (Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Cancer/Tumor Profiling (Epigenetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Cancer/Tumor Profiling (Epigenetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Cancer/Tumor Profiling (Metabolomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Cancer/Tumor Profiling (Metabolomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Cancer/Tumor Profiling (Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Cancer/Tumor Profiling (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Cancer/Tumor Profiling (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Cancer/Tumor Profiling (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Cancer/Tumor Profiling (Prognostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Cancer/Tumor Profiling (Prognostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Cancer/Tumor Profiling (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Cancer/Tumor Profiling (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Cancer/Tumor Profiling Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Cancer/Tumor Profiling Industry: SWOT Analysis
  • Figure 101: Global: Cancer/Tumor Profiling Industry: Value Chain Analysis
  • Figure 102: Global: Cancer/Tumor Profiling Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer/Tumor Profiling Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
  • Table 3: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technique (in Million US$), 2024-2032
  • Table 5: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cancer/Tumor Profiling Market: Competitive Structure
  • Table 8: Global: Cancer/Tumor Profiling Market: Key Players